Skip to main content
. 2019 Jan 3;104(6):2031–2040. doi: 10.1210/jc.2018-02298

Figure 2.

Figure 2.

aHRs for CVD in subjects with AAD vs matched controls according to sex and hydrocortisone/fludrocortisone dosing, adjusted for diabetes and COPD in all models and tertiles of hydrocortisone dosing or halves of fludrocortisone dosing, as appropriate.